611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
FDA Warns of Deaths Tied to Tainted Synthetic PotWhere Are Opioid Painkillers Prescribed the Most?In the ICU, Patients' Relatives Often Mum About Care ConcernsResetting E-Prescriptions for Opioids Helps Curb Use: StudyHealth Tip: If You're 45 or Older, Get Screened for Colorectal CancerRed Cross Issues Nationwide Call for Blood DonationsDoctor Burnout Widespread, Helps Drive Many Medical ErrorsWarming Climate, More AC -- and More Unhealthy Smog AheadEven at 'Safe' Levels, Air Pollution May Boost Diabetes RiskDeath Certificate Data May Miss Many Opioid ODs: StudyRaise the Bar on CPR, Heart Group SaysWhen DEA Cracked Down on Opioids, Abusers Moved to Black Market: StudyStigma of Safe Needle Exchanges Lingers Despite Opioid EpidemicAHA: Drones a Lifesaver for Cardiac Arrest Patients?Millions Die Worldwide Each Year for Lack of Quality CareTips for Handling a Medical EmergencyAHA: Lifesaving Info Not Always a 911 Call AwayMany, But Not All, Hospitals Require Flu Shots for StaffersCancer Care Twice as Costly in U.S. Versus CanadaAHA: Health Concerns Haunt Puerto Rico as New Hurricane Season BeginsPot, Opioids Now Rival Alcohol as Factor in Driver DeathsThe ER or Urgent Care?Trumps Signs Bill Allowing Terminal Patients to Try Unproven MedicinesTough State Drunk Driving Laws Save LivesE-Cigarettes Don't Help Smokers Quit, But Cash MightSmall World? Not With One-Quarter Obese by 2045A Pill to Protect You From the Sun? Don't Believe It, FDA SaysMost Hospitals Aren't Ready for Mass Tragedies, ER Docs SayAHA: Making America's Doctors Look More Like AmericaLanguage Used in Medical Record Can Affect Patient CareNonprofit Manufacturer Could Keep Generic Drug Costs DownOpioid Makers' Perks to Docs Tied to More PrescriptionsFDA Targets Clinics Offering Unapproved Stem Cell TherapiesLittle 'Quit-Smoking' Help at U.S. Mental Health CentersIs Testing for Zika in U.S. Blood Supply Worth the Cost?'Smoke-Free' Rooms Still Loaded With Smoke Residues, Study FindsAHA: Smoke-Free Laws Do Seem to Help Young Adults' HeartsAHA: Poverty Levels Key to States' Performance on Heart DiseaseSimple Drug Packaging Change Could Save Toddlers' LivesFDA Cracks Down on Dangerous E-Cig Liquids That Resemble Cookies, CandyNew Clinic Satisfaction Tool Provides Real-Time FeedbackUnused Meds? Saturday Is National Drug Take Back DayA Doctor's Age May Matter With Emergency SurgeryPatients Prefer Doctors Who Engage in Face-to-Face VisitsU.S. Better Able to Tackle Health Emergencies: ReportFirst Opioid Lawsuit Targeting Pharmacy Benefit ManagersMost Doctors' Offices Don't Offer Flexibility for UninsuredSafety Info for Opioids Found LackingNonoptimized Drug Therapy Costs More Than $500 Billion AnnuallyFDA Cracks Down on Caffeine-Loaded Supplements
Questions and AnswersLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Nonprofit Manufacturer Could Keep Generic Drug Costs Down


HealthDay News
Updated: May 16th 2018

new article illustration

WEDNESDAY, May 16, 2018 (HealthDay News) -- A nonprofit manufacturer could help keep generic drug prices down and maintain their supply, according to a perspective piece published in the May 17 issue of the New England Journal of Medicine.

Dan Liljenquist, J.D., from Intermountain Healthcare in Salt Lake City, and colleagues discuss generic drug market failure, whereby a generic drug manufacturer increases the drug price, which can compromise care.

The authors note that other manufacturers do not enter the seemingly lucrative generic drug market partly because of the initial investment required and cost of obtaining U.S. Food and Drug Administration approval. In addition, there is concern that once a second drug is approved for the condition, the manufacturer of the original generic will reduce the price of its product. One solution is establishment of a nonprofit generic drug manufacturer with the aim of producing affordable versions of essential drugs and ensuring a stable supply. A consortium of hospitals and health plans is currently developing a nonprofit generic drug manufacturer named Project Rx. The nonprofit manufacturer, which has a legal constraint that it cannot distribute earnings, will pursue a cost-plus strategy, generating enough revenue to cover costs and maintain a limited surplus for financial viability rather than profit maximization.

"We believe that Project Rx may drive other nonprofit and for-profit manufacturers to enter generic-drug markets, compete among themselves, and collectively improve market efficiency and broaden access to generic drugs," the authors write.

One author disclosed serving as a volunteer on the advisory committee of Project Rx.

Abstract/Full Text